Federal Circuit Reverses Summary Judgment of Invalidity for Patent Covering Prescription Sorting Machines

Aug 30, 2016

Reading Time : 1 min

The patent at issue, U.S. Patent No. 6,910,601, discussed a “collating unit,” which corrals prescription containers after they have been filled with a prescription by an automatic dispensing system. The asserted claims were directed to such a collating unit, but did not recite a limitation for how the containers were sorted and stored. The district court determined that the ’601 patent disclosed only a collating unit that used patient-specific information for sorting and storing the containers. Citing Gentry Gallery and ICU Medical, the district court ruled that the claims were invalid for being broader than the disclosure.

The Federal Circuit disagreed. That court drew a distinction between the disclosures in the ’601 patent and the patents involved in Gentry Gallery and ICU Medical. In Gentry Gallery and ICU Medical, “the specifications clearly limited the scope of the claims in ways that the claims clearly did not.” But, even though “much of the ’601 patent’s specification focuse[d] on” a type of embodiment using patient-specific information, the Federal Circuit held that the ’601 patent was not so limited. Rather, the specification disclosed other problems which the invention could solve by using different types of information, such as the type of medication or the date the prescription is filled. Additionally, the Federal Circuit found support in the originally-filed claims. As part of the disclosure, these claims supported the broader invention because they, too, were not limited to embodiments relying on patient-specific information.

ScriptPro LLC v. Innovation Assocs., Inc., No. 2015-1565, 2016 WL 4269920 (Fed. Cir. Aug. 15, 2016).

[Moore (opinion), Taranto, and Hughes]

Share This Insight

Previous Entries

IP Newsflash

November 17,2025

The district of Delaware recently denied a defendant’s partial motion to dismiss pre-suit willful infringement from the litigation, finding instead that the allegations taken as a whole were sufficient to support pre-suit willfulness at the pleading stage. Specifically, the court found that the allegations as to the defendant’s involvement in a related foreign opposition proceeding and participation in the relevant industry were accompanied by detailed factual support that sufficiently pleaded willful infringement for the pre-suit period.

...

Read More

IP Newsflash

November 14, 2025

The Ninth Circuit recently reversed a district court’s decision to strike a plaintiff’s trade secret claims under the Defend Trade Secrets Act (DTSA) at the discovery stage. In doing so, the Ninth Circuit made clear that under the DTSA, whether a party defined their trade secret with sufficient particularity is a question of fact that generally does not lend itself to resolution in the absence of at least some discovery. This ruling contrasts with the California Uniform Trade Secrets Act (CUTSA), which requires a party to define their trade secrets with reasonable particularity before commencing discovery.

...

Read More

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.